The Challenges in Manufacturing Biologics [Video]

This content is brought to you by Amgen This video summarizes the complex process of creating biologics from start to finish and describes some of the unique challenges-- and tremendous effort-- involved in delivering safe and effective biologics.

Related Videos

Related Content

Advertisement

December 20th 2024

FDA Approves Seventh Ustekinumab Biosimilar to Reference Stelara

Cameron Santoro

The FDA granted approval to Steqeyma (ustekinumab-stba) for inflammatory conditions, making it the seventh biosimilar to reference Stelara after a year of multiple ustekinumab biosimilar approvals.

July 30th 2024

Bridging the Vaccination Gap: Insights on Global Immunization Challenges

Maggie L. Shaw

On this episode of Managed Care Cast, we speak with Jeffery A. Goad, PharmD, MPH, 2024-2025 president of the National Foundation for Infectious Diseases, on the recent report from the World Health Organization and UNICEF on public immunization rates, with national and global health implications.

December 18th 2024

Year-End Spending Bill to Feature Reforms for Pharmacy Benefit Managers and Telehealth Access

Giuliana Grossi

The health care provisions include key reforms targeting pharmacy benefit managers, extensions of Medicare telehealth flexibilities, and measures aimed at combating the opioid crisis and preparing for future pandemics.

June 27th 2024

Double Trouble: High-Deductible Plans Raise Maternity Care Costs Across 2 Calendar Years

Brooke McCormick

On this episode of Managed Care Cast, we're talking with the author of a study published in the June 2024 issue of The American Journal of Managed Care® about how annual high-deductible insurance plans increase maternity care costs when pregnancies cross 2 calendar years.

December 16th 2024

Smart, Effective Advocacy: Clif Gaus’ Vision for Value-Based Care

Maggie L. Shaw

Since its founding in 2012, the National Association of ACOs has evolved from a group of 30 to 477 accountable care organization members covering 9.2 million beneficiary lives.

December 16th 2024

Uptake of Rituximab Biosimilars in Medicare and Medicaid in 2019-2022

Jingjing Qian, PhD

Significant uptake of rituximab biosimilars in Medicare and Medicaid occurred within the first 4 years of marketing in the US.

Related Content

Advertisement

December 20th 2024

FDA Approves Seventh Ustekinumab Biosimilar to Reference Stelara

Cameron Santoro

The FDA granted approval to Steqeyma (ustekinumab-stba) for inflammatory conditions, making it the seventh biosimilar to reference Stelara after a year of multiple ustekinumab biosimilar approvals.

July 30th 2024

Bridging the Vaccination Gap: Insights on Global Immunization Challenges

Maggie L. Shaw

On this episode of Managed Care Cast, we speak with Jeffery A. Goad, PharmD, MPH, 2024-2025 president of the National Foundation for Infectious Diseases, on the recent report from the World Health Organization and UNICEF on public immunization rates, with national and global health implications.

December 18th 2024

Year-End Spending Bill to Feature Reforms for Pharmacy Benefit Managers and Telehealth Access

Giuliana Grossi

The health care provisions include key reforms targeting pharmacy benefit managers, extensions of Medicare telehealth flexibilities, and measures aimed at combating the opioid crisis and preparing for future pandemics.

June 27th 2024

Double Trouble: High-Deductible Plans Raise Maternity Care Costs Across 2 Calendar Years

Brooke McCormick

On this episode of Managed Care Cast, we're talking with the author of a study published in the June 2024 issue of The American Journal of Managed Care® about how annual high-deductible insurance plans increase maternity care costs when pregnancies cross 2 calendar years.

December 16th 2024

Smart, Effective Advocacy: Clif Gaus’ Vision for Value-Based Care

Maggie L. Shaw

Since its founding in 2012, the National Association of ACOs has evolved from a group of 30 to 477 accountable care organization members covering 9.2 million beneficiary lives.

December 16th 2024

Uptake of Rituximab Biosimilars in Medicare and Medicaid in 2019-2022

Jingjing Qian, PhD

Significant uptake of rituximab biosimilars in Medicare and Medicaid occurred within the first 4 years of marketing in the US.